首页> 美国卫生研究院文献>Infection and Immunity >Genetic Fusions of Heat-Labile (LT) and Heat-Stable (ST) Toxoids of Porcine Enterotoxigenic Escherichia coli Elicit Neutralizing Anti-LT and Anti-STa antibodies
【2h】

Genetic Fusions of Heat-Labile (LT) and Heat-Stable (ST) Toxoids of Porcine Enterotoxigenic Escherichia coli Elicit Neutralizing Anti-LT and Anti-STa antibodies

机译:猪产肠毒素的大肠杆菌热不稳定(LT)和热稳定(ST)类毒素的遗传融合诱导中和抗LT和抗STa抗体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Enterotoxigenic Escherichia coli (ETEC) strains are a major cause of diarrheal disease in humans and farm animals. E. coli fimbriae, or colonization factor antigens (CFAs), and enterotoxins, including heat-labile enterotoxins (LT) and heat-stable enterotoxins (ST), are the key virulence factors in ETEC diarrhea. Unlike fimbriae or LT, STa has not often been included as an antigen in development of vaccines against ETEC diarrhea because of its poor immunogenicity. STa becomes immunogenic only after being coupled with a strongly immunogenic carrier protein. However, native or shorter STa antigens either had to retain toxic activity in order to become antigenic or elicited anti-STa antibodies that were not sufficiently protective. In this study, we genetically mutated the porcine LT (pLT) gene for a pLT192(R→G) toxoid and the porcine STa (pSTa) gene for three full-length pSTa toxoids [STa11(N→K), STa12(P→F), and STa13(A→Q)] and used the full-length pLT192 as an adjuvant to carry the pSTa toxoid for pLT192:pSTa-toxoid fusion antigens. Rabbits immunized with pLT192:pSTa12 or pLT192:pSTa13 fusion protein developed high titers of anti-LT and anti-STa antibodies. Furthermore, rabbit antiserum and antifecal antibodies were able to neutralize purified cholera toxin (CT) and STa toxin. In addition, preliminary data suggested that suckling piglets born by a sow immunized with the pLT192:pSTa13 fusion antigen were protected when challenged with an STa-positive ETEC strain. This study demonstrated that pSTa toxoids are antigenic when fused with a pLT toxoid and that the elicited anti-LT and anti-STa antibodies were protective. This fusion strategy could provide instructive information to develop effective toxoid vaccines against ETEC-associated diarrhea in animals and humans.
机译:肠毒素大肠杆菌(ETEC)菌株是人类和农场动物腹泻病的主要原因。大肠杆菌菌毛或定居因子抗原(CFAs)和肠毒素,包括不耐热肠毒素(LT)和热稳定肠毒素(ST),是ETEC腹泻的关键毒力因子。与菌毛或LT不同,STa由于其免疫原性差,因此在开发针对ETEC腹泻的疫苗时并未经常被包括为抗原。仅在与强免疫原性载体蛋白偶联后,STa才具有免疫原性。但是,天然或较短的STa抗原要么必须保留毒性活性,要么成为抗原或引发的抗STa抗体,但它们的保护作用不足。在这项研究中,我们对pLT192(R→G)类毒素的猪LT(pLT)基因和三个全长pSTa类毒素的猪STa(pSTa)基因进行了基因突变[STa11(N→K),STa12(P→ F)和STa13(A→Q)],并使用全长pLT192作为佐剂,携带pST192:pSTa-类毒素融合抗原的pSTa类毒素。用pLT192:pSTa12或pLT192:pSTa13融合蛋白免疫的兔子产生了高滴度的抗LT和抗STa抗体。此外,兔抗血清和抗粪便抗体能够中和纯化的霍乱毒素(CT)和STa毒素。此外,初步数据表明,当用STa阳性ETEC菌株攻击时,用pLT192:pSTa13融合抗原免疫的母猪所生的乳猪受到保护。这项研究表明,pSTa类毒素与pLT类毒素融合时具有抗原性,并且引发的抗LT和抗STa抗体具有保护性。这种融合策略可以提供指导性信息,以开发有效的抗动物和人类ETEC相关性腹泻的类毒素疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号